NYSEAMERICAN : VNRX
VolitionRx Limited — Financial statements
Healthcare · Medical Devices · United States
Last price 0.1953 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
VolitionRx Limited (VNRX) reported revenue of 2.46M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.46M | 1.73M | 1.23M | 775.30K | 306.39K | 90.03K |
| Gross Profit | 2.46M | 1.73M | 1.23M | 775.30K | 306.39K | 90.03K |
| Selling, General & Admin | 12.50M | 13.38M | 13.85M | 17.21M | 16.75M | 15.40M |
| Research & Development | 9.41M | 10.08M | 14.41M | 19.55M | 15.33M | 13.02M |
| Operating Expenses | 21.91M | 23.47M | 28.26M | 36.76M | 32.09M | 28.42M |
| Operating Income | -19.45M | -21.74M | -27.02M | -35.99M | -31.78M | -28.33M |
| Interest Expense | -3.67M | -2.49M | -340.36K | -221.62K | -173.09K | -155.80K |
| Interest & Investment Income | 461.00 | 600.00 | 9.95K | 93.32K | 125.27K | 2.73K |
| Other Non Operating Income (Expenses) | -1.04M | 722.15K | 132.13K | 454.76K | 1.23M | 1.52M |
| EBT Excluding Unusual Items | -24.15M | -23.51M | -27.22M | -35.66M | -30.60M | -26.96M |
| Gain (Loss) on Sale of Assets | 3.60K | 1.83K | -34.73K | -15.84K | -26.17K | |
| Other Unusual Items | -1.58M | |||||
| Pretax Income | -25.73M | -23.50M | -27.26M | -35.68M | -30.60M | -26.99M |
| Earnings From Continuing Operations | -25.73M | -23.50M | -27.26M | -35.68M | -30.60M | -26.99M |
| Minority Interest in Earnings | 91.44K | 146.30K | 290.15K | 358.00K | 329.68K | 175.12K |
| Net Income | -25.64M | -23.36M | -26.97M | -35.32M | -30.27M | -26.81M |
| Net Income to Common | -26.10M | -23.36M | -26.97M | -35.32M | -30.27M | -26.81M |
| Shares Outstanding (Basic) | 6.86M | 5.34M | 4.33M | 3.56M | 2.77M | 2.63M |
| Shares Outstanding (Diluted) | 6.86M | 5.34M | 4.33M | 3.56M | 2.77M | 2.63M |
| EPS (Basic) | -3.80 | -4.37 | -6.23 | -9.92 | -10.94 | -10.18 |
| EPS (Diluted) | -3.80 | -4.37 | -6.23 | -9.92 | -10.94 | -10.18 |
| Free Cash Flow | -19.58M | -19.77M | -26.17M | -19.15M | -16.85M | -21.83M |
| Free Cash Flow Per Share | -2.85 | -3.70 | -6.05 | -5.38 | -6.09 | -8.29 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -791.16% | -1,258.47% | -2,190.90% | -4,641.77% | -10,372.36% | -31,468.96% |
| Profit Margin | -1,061.82% | -1,352.16% | -2,186.27% | -4,555.52% | -9,879.11% | -29,782.49% |
| Free Cash Flow Margin | -796.75% | -1,144.67% | -2,121.68% | -2,469.59% | -5,498.81% | -24,243.32% |
| EBITDA | -18.57M | -20.75M | -25.91M | -34.84M | -30.84M | -27.39M |
| D&A For EBITDA | 874.46K | 983.71K | 1.11M | 1.15M | 936.08K | 945.37K |
| EBIT | -19.45M | -21.74M | -27.02M | -35.99M | -31.78M | -28.33M |
| Revenue as Reported | 2.46M | 1.73M | 1.23M | 775.30K | 306.39K | 90.03K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.79M | 1.12M | 3.26M | 20.73M | 10.87M | 20.58M |
| Cash & Short-Term Investments | 2.79M | 1.12M | 3.26M | 20.73M | 10.87M | 20.58M |
| Receivables | 277.36K | 317.81K | 110.57K | 242.62K | 72.61K | 12.51K |
| Prepaid Expenses | 689.01K | 433.68K | 338.66K | 521.37K | 784.92K | 598.37K |
| Other Current Assets | 335.59K | 192.41K | 343.14K | 360.12K | 447.57K | 786.64K |
| Total Current Assets | 4.09M | 2.06M | 4.06M | 21.85M | 12.17M | 21.98M |
| Property, Plant & Equipment | 3.90M | 4.52M | 5.03M | 6.07M | 6.01M | 5.29M |
| Other Intangible Assets | 305.13K | 316.70K | 313.75K | 23.89K | 110.50K | 216.88K |
| Total Assets | 8.30M | 6.90M | 9.40M | 27.95M | 18.30M | 27.49M |
| Accounts Payable | 3.56M | 2.92M | 2.77M | 3.21M | 3.04M | 1.54M |
| Accrued Expenses | 2.72M | 4.29M | 3.51M | 3.99M | 2.94M | 3.90M |
| Current Portion of Long-Term Debt | 4.49M | 3.31M | 860.22K | 1.21M | 1.07M | 797.86K |
| Current Portion of Leases | 258.32K | 304.71K | 268.49K | 247.89K | 291.18K | 220.12K |
| Current Unearned Revenue | 177.58K | 353.85K | 230.00K | 106.60K | 10.00M | 12.51K |
| Other Current Liabilities | 2.28M | 1.05M | 158.87K | 182.50K | 41.84K | 43.10K |
| Total Current Liabilities | 13.49M | 12.23M | 7.79M | 8.94M | 17.39M | 6.52M |
| Long-Term Debt | 6.22M | 7.26M | 3.95M | 3.62M | 2.78M | 2.27M |
| Long-Term Leases | 439.76K | 594.42K | 739.02K | 778.08K | 836.22K | 728.39K |
| Long-Term Unearned Revenue | 21.23M | 21.94M | 22.66M | 22.89M | ||
| Other Long-Term Liabilities | 460.91K | 473.65K | 361.24K | 422.71K | 420.47K | 253.22K |
| Total Liabilities | 41.84M | 42.49M | 35.51M | 36.66M | 21.42M | 9.77M |
| Common Stock | 12.04K | 125.78K | 96.10K | 81.90K | 57.87K | 53.77K |
| Additional Paid-In Capital | 235.26M | 218.82M | 204.15M | 194.45M | 164.40M | 154.73M |
| Retained Earnings | -267.35M | -252.90M | -229.54M | -202.58M | -167.26M | -136.99M |
| Comprehensive Income & Other | -88.45K | -295.07K | 385.63K | 243.94K | 227.10K | 148.33K |
| Total Common Equity | -32.16M | -34.25M | -24.91M | -7.80M | -2.57M | 17.94M |
| Minority Interest | -1.37M | -1.35M | -1.20M | -909.97K | -551.97K | -222.29K |
| Shareholders' Equity | -33.54M | -35.59M | -26.11M | -8.71M | -3.13M | 17.72M |
| Total Liabilities & Equity | 8.30M | 6.90M | 9.40M | 27.95M | 18.30M | 27.49M |
| Total Debt | 11.41M | 11.46M | 5.82M | 5.86M | 4.97M | 4.02M |
| Net Cash (Debt) | -8.62M | -10.35M | -2.56M | 14.87M | 5.89M | 16.56M |
| Net Cash Per Share | -1.26 | -1.94 | -0.59 | 4.18 | 2.13 | 6.29 |
| Filing Date Shares Outstanding | 13.65M | 7.92M | 4.83M | 4.10M | 3.15M | 2.69M |
| Total Common Shares Outstanding | 12.04M | 6.29M | 4.80M | 4.09M | 2.89M | 2.69M |
| Working Capital | -9.40M | -10.17M | -3.73M | 12.91M | -5.21M | 15.46M |
| Book Value Per Share | -2.67 | -5.45 | -5.18 | -1.91 | -0.89 | 6.67 |
| Tangible Book Value | -32.47M | -34.56M | -25.22M | -7.83M | -2.69M | 17.73M |
| Tangible Book Value Per Share | -2.70 | -5.50 | -5.25 | -1.91 | -0.93 | 6.59 |
| Land | 137.00K | 140.81K | 124.21K | 132.47K | 128.79K | 136.52K |
| Buildings | 4.07M | 4.18M | 3.62M | 3.72M | 3.37M | 3.47M |
| Machinery | 5.97M | 6.10M | 5.66M | 5.86M | 5.21M | 3.93M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -25.64M | -23.36M | -26.97M | -35.32M | -30.27M | -26.81M |
| Depreciation & Amortization | 1.13M | 1.22M | 1.34M | 1.41M | 1.19M | 1.15M |
| Other Amortization | 2.49M | 1.96M | ||||
| Loss (Gain) From Sale of Assets | -3.60K | -1.83K | 34.73K | 15.84K | 26.17K | |
| Stock-Based Compensation | 939.28K | 1.74M | 1.27M | 2.29M | 3.11M | 5.12M |
| Other Operating Activities | 3.55M | -351.94K | -318.91K | -598.31K | -329.68K | -175.12K |
| Change in Accounts Receivable | -87.76K | -207.23K | 132.04K | -169.67K | -72.61K | -12.51K |
| Change in Accounts Payable | -135.22K | 77.98K | -1.22M | 1.22M | 548.61K | 522.22K |
| Change in Unearned Revenue | -1.38M | -601.09K | -106.60K | 13.00M | 9.99M | 12.51K |
| Change in Other Net Operating Assets | -417.66K | -155.45K | -57.51K | 80.64K | 552.63K | -678.33K |
| Operating Cash Flow | -19.56M | -19.68M | -25.89M | -18.06M | -15.28M | -20.85M |
| Capital Expenditures | -21.97K | -89.56K | -277.50K | -1.08M | -1.57M | -973.56K |
| Sale (Purchase) of Intangibles | -296.35K | |||||
| Investing Cash Flow | -21.97K | -89.56K | -573.85K | -1.08M | -1.57M | -973.56K |
| Long-Term Debt Issued | 7.78M | 1.37M | 1.85M | 1.52M | 592.42K | |
| Long-Term Debt Repaid | -1.76M | -1.14M | -1.03M | -1.31M | -813.93K | |
| Net Debt Issued (Repaid) | 1.10M | 6.02M | 233.23K | 827.08K | 209.28K | -221.51K |
| Issuance of Common Stock | 19.33M | 11.17M | 8.59M | 28.39M | 6.74M | 23.22M |
| Repurchase of Common Stock | -146.40K | -210.03K | -139.94K | -235.65K | -180.47K | -130.43K |
| Other Financing Activities | 66.66K | 111.04K | -28.21K | 3.22K | 172.78K | -10.16K |
| Financing Cash Flow | 20.35M | 17.09M | 8.66M | 28.98M | 6.94M | 22.86M |
| Foreign Exchange Rate Adjustments | -231.59K | 532.63K | 344.67K | 27.00K | 195.63K | 106.50K |
| Net Cash Flow | 535.00K | -2.15M | -17.47M | 9.86M | -9.71M | 1.14M |
| Free Cash Flow | -19.58M | -19.77M | -26.17M | -19.15M | -16.85M | -21.83M |
| Free Cash Flow Margin | -796.75% | -1,144.67% | -2,121.68% | -2,469.59% | -5,498.81% | -24,243.32% |
| Free Cash Flow Per Share | -2.85 | -3.70 | -6.05 | -5.38 | -6.09 | -8.29 |
| Levered Free Cash Flow | -9.21M | -8.52M | -15.56M | -28.37M | -6.61M | -12.68M |
| Unlevered Free Cash Flow | -9.41M | -8.92M | -15.35M | -28.23M | -6.51M | -12.58M |
| Cash Interest Paid | 303.59K | 280.72K | 340.36K | 221.62K | 173.11K | 155.80K |
| Change in Working Capital | -2.02M | -885.80K | -1.25M | 14.14M | 11.02M | -156.11K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.77M | 31.39M | 57.85M | 56.42M | 139.78M | 168.10M |
| Enterprise Value | 11.39M | 41.13M | 57.18M | 49.11M | 127.37M | 148.69M |
| Last Close Price | 0.20 | 5.11 | 12.00 | 14.34 | 48.60 | 62.80 |
| PS Ratio | 1.13 | 18.17 | 46.90 | 72.77 | 456.20 | 1,867.09 |
| PB Ratio | -0.88 | -2.22 | -6.48 | -44.70 | 9.49 | |
| P/TBV Ratio | 9.48 | |||||
| EV/Sales Ratio | 4.64 | 23.81 | 46.36 | 63.34 | 415.72 | 1,651.50 |
| Debt / Equity Ratio | -0.34 | -0.32 | -0.22 | -0.67 | -1.59 | 0.23 |
| Net Debt / Equity Ratio | -0.26 | -0.29 | -0.10 | 1.71 | 1.89 | -0.94 |
| Net Debt / EBITDA Ratio | -0.46 | -0.50 | -0.10 | 0.43 | 0.19 | 0.60 |
| Net Debt / FCF Ratio | -0.44 | -0.52 | -0.10 | 0.78 | 0.35 | 0.76 |
| Asset Turnover | 0.29 | 0.21 | 0.07 | 0.03 | 0.01 | 0.00 |
| Quick Ratio | 0.23 | 0.12 | 0.43 | 2.35 | 0.63 | 3.16 |
| Current Ratio | 0.30 | 0.17 | 0.52 | 2.44 | 0.70 | 3.37 |
| Return on Equity (ROE) | -419.30% | -158.69% | ||||
| Return on Assets (ROA) | -142.94% | -166.70% | -90.44% | -97.27% | -86.76% | -66.03% |
| Return on Capital Employed (ROCE) | 374.60% | 407.90% | -1,679.80% | -189.30% | -3,496.30% | -135.10% |
| Earnings Yield | -1,947.99% | -74.41% | -46.62% | -62.60% | -21.65% | -15.95% |
| FCF Yield | -706.06% | -63.00% | -45.24% | -33.94% | -12.05% | -12.98% |
| Buyback Yield / Dilution | -44.16% | -23.46% | -21.47% | -28.70% | -5.12% | -16.29% |